PHARMA COMPANIES. Abbott Laboratories. Bristol-Myers Squibb
|
|
- Sandra Kerrie Owen
- 6 years ago
- Views:
Transcription
1 People on themove PHARMA COMPANIES Éric Chenier, former Product Manager, Pediatric Biaxin, has been appointed Product Manager, Biaxin XL, Primary Care Division, at. Sybil Dahan, former General Manager in Sweden, has been appointed Commercial Director, Immunology, at. Copyright Georges Ged, former Medical Representative with Vanguard, has been appointed Product Manager, Cardiovascular, Primary Care Division, at. Not for Sale or Commercial Distribution Unauthorised use prohibited. Authorised users can download, display, view and print a single copy for personal use Olivier Illouz, former Medical Advisor with sanofi aventis, has been appointed Medical Advisor, Rheumatology/Immunology, Humira, at. Éric Chenier Georges Ged Sybil Dahan Olivier Illouz Teresa Atkinson, former Training Manager, Continuous Education, has been appointed Primary Market Research Analyst, CV-Met Business Unit, at. Noel-Alexandre Bertout, former Associate Marketing Director Europe, Sprycel, has been appointed Vice-President, Oncology Business Unit, at. Teresa Atkinson Noel-Alexandre Bertout 57
2 Cont d Lee Courchesne Nancy Cribb Lee Courchesne, former National Medical Manager, has been appointed Product Manager, Avapro, at. Nancy Cribb, former Senior Consultant, Strategic Market Research, at HIT Research, has been appointed Primary Market Research Analyst, Oncology Business Unit, at. Rania Ijhaish-Nasraoui, former Senior Market Research Manager, Pain/Inflammation/Urology Portfolio, at, has been appointed Senior Product Manager, Plavix, at. Rania Ijhaish- Nasraoui David Lambrou David Lambrou, former Senior Analyst, Commercial Research, Diabetes, at sanofi aventis, has been appointed Primary Market Research Analyst, Virology/Immunology Business Unit, at. Benoît L Archevêque, former Product Portfolio Manager, at Pharmascience, has been appointed Virology/Immunology Business Unit Analyst, at. Martial Lebeau, former Market Analyst, at Sandoz, has been appointed Customer Segmentation Analyst, at. Benoît L Archevêque Martial Lebeau Brigitte Lecuyer, former Financial Analyst, has been appointed Marketing Research Data Analyst, at. Brad McLean, former Brand Manager, Plavix, at sanofi aventis, has been appointed Product Manager, Abilify, at. Brigitte Lecuyer Brad McLean 58
3 Cont d Kevin Romanesky, MBA graduate from Université Laval, has been appointed CV-Met Business Unit Analyst, at. CCPE Louise Guay, formerly in the Learning & Development Department, at, has joined the Council for Continuing Pharmaceutical Education (CCPE), as the Production and Promotion Manager. Kevin Romanesky Louise Guay CCPE King Pharmaceuticals Ava Armstrong, former Senior Marketing Manager, has been promoted to Director of Marketing, at King Pharmaceuticals Canada. Jill Tetrault, formerly of Eli Lilly, has joined King Pharmaceuticals Canada as District Sales Manager. Merck Frosst Ava Armstrong King Pharmaceuticals Jill Tetrault King Pharmaceuticals Howard Wiseman, former Product Manager, Cordaptive, has been appointed Product Manager, COZAAR/HYZAAR, at Merck Frosst. Kally Yannopoulos, former Product Manager, COZAAR/HYZAAR, has been appointed Multi-Channel Marketing Manager, at Merck Frosst. Novartis Pharmaceuticals Patrick Faubert, former Associate Manager, CME/Marketing & Sales Capabilities, has been promoted to Manager, CME/Marketing & Sales Capabilities, at Novartis Pharmaceuticals. Howard Wiseman Merck Frosst Patrick Faubert Novartis Pharmaceuticals Paladin Labs Ashok Bhaseen, former Commercial Director for Pacific, Asia, Africa and Australia region, at and Director, National Accounts, at IMS Health, has been appointed Group Director, Woman s Health & Allergy Products, at Paladin Labs. Ashok Bhaseen Paladin Labs 59
4 Paladin Labs Cont d François Leblond Paladin Labs Irena Fedorencikiene François Leblond, former Product Manager at Santé Naturelle D Adrien Gagnon and Product Manager at Schering-Plough, has been appointed Product Manager, Plan B, at Paladin Labs. Irena Fedorencikiene, former Manager, Specialty Business Insight, has been promoted to Brand Manager, Anti-Infectives, at. Vanessa Guttman- Horvath Nancy Lahaie Vanessa Guttman-Horvath, former Product Manager, Biaxin XL, at, has been appointed Senior Brand Manager, Celebrex/Arthrotec, at. Nancy Lahaie, former Marketing Manager, Molecular Diagnostics Division, at Roche Diagnostics, has been appointed Senior Brand Manager, Detrol, at. Patrick Leduc, former Associate Sales Director Québec, has been promoted to Brand Manager, Relpax, at. Paul Morris, former Brand Manager, Ophthalmology, has been promoted to Senior Brand Manager, Ophthalmology, at. Patrick Leduc Robert Petrie Robert Petrie, formerly with Merck Frosst, has been appointed Senior Brand Manager, Aricept, at. sanofi aventis Julie Guay, former Senior Brand Manager, Avapro/Avalide, has been appointed Senior Brand Manager, Multaq, at sanofi aventis. Brigitte Renauld, former Senior Brand Manager, Plavix, has been appointed Sales Manager and Regional CHE Coordinator, Lovenox, at sanofi aventis. Julie Guay sanofi aventis Brigitte Renauld sanofi aventis 60
5 Smith & Nephew Marc-Eric Beaudoin, former Associate Brand Manager, has been promoted to Brand Manager, at Smith & Nephew. Roberta Porter, former Brand Manager, has been promoted to Senior Brand Manager, at Smith & Nephew. Minnie Romanelli, former Marketing Coordinator, has been promoted to Associate Brand Manager, at Smith & Nephew. TEVA Neuroscience Marc-Eric Beaudoin Smith & Nephew Roberta Porter Smith & Nephew Emidio De Carolis, PhD, having previously held management positions in the Medical and Marketing departments at and who, most recently was District Manager, Oncology Portfolio at, has been appointed Director of Marketing, at TEVA Neuroscience. Minnie Romanelli Smith & Nephew Emidio De Carolis TEVA Neuroscience Announcement Announces Guy Lallemand as new Spanish-Speaking South America (SSA) Regional Director Guy Lallemand, Spanish-Speaking South America (SSA) Regional Director, Canada Guy Lallemand at has been promoted to Regional Director, SSA, effective July 1st. Further, in his new role, Guy joins the Canada-Latin America-Africa-Middle East Area Leadership Team (ALT). He will be based within the SSA region in Bogota, Colombia. As of July 1st, the Country Managers for Chile, Ecuador, Argentina, Venezuela, Peru and Colombia will report to Guy. In his pharmaceutical career that spans 28 years of industry experience, Guy has held several key roles at Canada since 2000, when he joined the Canada Leadership Team as Vice President of Sales. Subsequently, as VP of Government Affairs, he led a team of 44 colleagues. Most recently, as Marketing VP, he established a center of excellence capability for marketing to ensure consistent application of best practices for common projects and manage innovation and costs more efficiently across brand names. Under his leadership, Canada acheived aggessive market growth and share retention in 2007 for major patent-protected products, such as Lipitor, Celebrex, Norvasc and Viagra and outstanding success in recent launches for Sutent and Champix. When Guy joined in 1993, he occupied the position of Director of Sales, Training and Operations. Shortly afterwards, he was promoted to Director of Sales for the Quebec/Atlantic Region. He has an MBA in Marketing and International Business and a Bachelor s Degree in Biochemistry, both from McGill University. 61
6 AD AGENCIES Anderson DDB Rose Burcheri, formerly with LXB Communication Marketing, has been appointed Senior Account Manager, at Anderson DDB. Marie-Estelle Peteytas, formerly with Annexe, has been appointed Account Coordinator, at Anderson DDB. Antibody Rose Burcheri Anderson DDB Marie-Estelle Peteytas Anderson DDB Neha Kumar, has joined Antibody as a Medical Associate. Susanna Wong, has joined Antibody as a Product Associate. Neha Kumar Antibody Susanna Wong Antibody TWO NEW BOOMERS Rhonda Berkowitz recently joined BOOM as Account Director after several years as Director of Client Services at AlterHealth where she developed successful adherence programs, marketing initiatives and clinical trials. With her creative approach to problem solving and a broad range of healthcare experience, Rhonda brings a new perspective to the growing team at BOOM. Teresa Leclair comes to BOOM from Anderson DDB, where she served as Senior Account Manager for several key clients. As BOOM s newest Account Director, Teresa offers experience across a wide range of therapeutic categories, along with an infectious enthusiasm that drives her commitment to client service.
7 LXB Communication Marketing Steven St-Pierre LXB Communication Marketing Steven St-Pierre, formerly with Nurun, Sympatico and Carat, has joined LXB Communication Marketing, as Director of Interactive Media. Phase V Rob Geller, has recently joined Phase V, as Senior Account Director. ZenithOptimedia Rob Geller Phase V Donna Tremblay, former Media Director at Marlowe and most recently, Senior Media Planner in the Wellness Division of Allard Johnson, has joined ZenithOptimedia, Montreal, as Account Manager, on the sanofi aventis business. SUPPLIERS Pangaea Wayne Childs, has been appointed Director, Pangaea Development & Training, at Pangaea Group of Companies. Integrated Healthcare Donna Tremblay ZenithOptimedia Maria Hajigeorgiou, previously with Elsevier Canada, The Medicine Group and Pulsus Group Inc., has joined Integrated Healthcare as a Senior Medical Writer. CPM Wayne Childs Pangaea Development & Training Maria Hajigeorgiou Integrated Healthcare 64
People. Move PHARMA COMPANIES. on the. Abbott Nutrition International. AstraZeneca. Axcan Pharma. Berlex. Bristol-Myers Squibb
People on the Move PHARMA COMPANIES Gary Schmid Abbott Nutrition International Crawford Wright AstraZeneca Abbott Nutrition International Gary Schmid, formerly Director of Marketing, Primary Care Division,
More informationPHARMA COMPANIES. Bristol-Myers Squibb. CAE Healthcare. Hoffmann-LaRoche
People on themove PHARMA COMPANIES Jacques Dessureault, former General Manager, Med Plan, has been appointed Vice-President, Cardiovascular/Metabolic Business Unit, at Bristol- Myers Squibb. James O. McPherson,
More informationPeople. Move PHARMA COMPANIES. on the. Abbott Laboratories. Biogen Idec. Bristol-Myers Squibb. Fournier Pharma. Gilles Fortin
People on the Move PHARMA COMPANIES Gilles Fortin Jonathan Lambert Gilles Fortin, most recently Director, Ross Products Division, has been appointed Director of Marketing, Primary Care Division, at. Jonathan
More informationPeople. Move. on the. Agata Babiarz has joined ANTIBODY Healthcare Communications as an Account Co-ordinator.
People on the Move Nicolas Gauvin Abbott Laboratories Ursula Lotz Abbott Laboratories Nicolas Gauvin, formerly Marketing Manager, GI, with Abbott Laboratories Canada, has been promoted to Marketing Manager,
More informationPeople. Move. on the. Pierre Benjamin, MD, has been appointed Project Leader, Zavesca, at Actelion Pharmaceuticals.
Pierre Gendron Guy Le Houillier Jocelyn Marquis Actelion Viken Paragamian Amgen Canada Stephane Langevin Pierre Benjamin Actelion Dr. Martin Holroyde Altana Pharma Lita Stewart Amgen Canada People on the
More informationon the Anne Berberi, formerly Product Manager, Diabetes, at Bristol-Myers Squibb, has been appointed Senior Brand Manager, HCV, at AbbVie.
PEOPLE Copyright on the MOVE Not for Sale or Commercial Distribution Unauthorised use prohibited. Authorised users can download, display, view and print a single copy for personal use PHARMA COMPANIES
More informationOther appointments: Chairman of the Advisory Committee of Zentiva Group, Industrial Advisor EQT.
Executive Committee Guido Oelkers Chief Executive Officer Born 1965. Employed since 2017. PhD in Strategic Management, University of South Australia, Master of Economics, South Bank University, London,
More informationBiotech Concerto #6 Investment Process December 2008
Biotech Concerto #6 Investment Process December 2008 Index Biotech Investment Characteristics Investment Policy Investment Team Scientific Advisory Board Deal Flow Attrition Rate From Screening to Decision
More informationL équipe de direction de Sandoz Canada est diversifiée et détient une vaste expérience dans l industrie pharmaceutique.
Published on Sandoz Canada (https://www.sandoz.ca) Home > Printer-friendly PDF > Dirigeants au Canada Canada Leadership L équipe de direction de Sandoz Canada est diversifiée et détient une vaste expérience
More informationSandoz Canada is led by a diverse team with extensive experience in the pharmaceutical industry.
Published on Sandoz Canada (https://www.sandoz.ca) Home > Printer-friendly PDF > Direction Sandoz Sandoz Leadership Tab: Canada Leadership Team Sandoz Canada is led by a diverse team with extensive experience
More informationPeter Smith. He has two daughters, Natalie and Christina, both of whom played for the McGill Martlets.
MANAGEMENT FORUM CONFERENCE LEADERS TEAMS AND LIFE NOVEMBER 17 2010 Peter Smith Peter Smith, a native of Lachine, Que., was appointed head coach at McGill University in 1999 and took a one-year sabbatical
More informationDean A. Connor. President & Chief Executive Officer, Sun Life Financial
Dean A. Connor President & Chief Executive Officer, Sun Life Financial Dean A. Connor was appointed President & Chief Executive Officer, Sun Life Financial on December 1, 2011, and is a member of the company
More informationYour Content Your Way
MY VIEW Your Content Your Way My View allows you to view only the topics you want to follow. Choose from a list of available topics, which are individualized for each publications, and design your own
More informationAMCo current. Medpace new in Sebia realised. Spire Healthcare partially realised. Healthcare. Sector insights. Our Healthcare portfolio in 2014
Sector insights The healthcare market is highly complex with global products delivered through local services and channels. The healthcare value chain is intricate, diverse and interdependent. It is a
More informationBaxter 2007 Investor Conference March 14, 2007
Joy A. Amundson is a corporate vice president of Baxter Healthcare Corporation and president of the company s BioScience business. In this position, she is responsible for the development and worldwide
More informationBayer Inc. Science for a Better Life. Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division
Bayer Inc. Science for a Better Life Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division Please review your career path to date, leading to your
More informationBOARD OF DIRECTORS. PETER WEHRLY Chair
BOARD OF DIRECTORS PETER WEHRLY Chair Peter Wehrly is the former group president of developed markets at Covidien, the manufacturer of medical devices with sales of over $10.7 billion (2014). Peter held
More informationAbbott 36 TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE. January 8, 2018 Brian Yoor, Executive Vice President, Finance and CFO
Abbott 36 TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE January 8, 2018 Brian Yoor, Executive Vice President, Finance and CFO FORWARD LOOKING STATEMENT Some statements in this presentation may be forward-looking
More informationGLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS
GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS PHM006K March 2016 Himani Singhi Wadhwa Project Analyst ISBN: 1-62296-254-0 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481
More informationCareer Day in Pharmaceutical Sciences 2015 Bios
Career Day in Pharmaceutical Sciences 2015 Bios Morning Session Talk Session (Madeleine Parent room, SSMU Building) 9:30 am 10:30 am Alternative Paths: Entrepreneurship and Innovation by Dr. Cliff Pavlovic
More informationShort & Long-Term Sustainability of Scientific Platforms Monday June 18, 2018
Scientific Platforms Meeting (SPM) 8 th Floor, Donadeo Innovation Centre for Engineering University of Alberta, 9211-116 Street NW, Edmonton, Alberta, T6G 1H9 Short & Long-Term Sustainability of Scientific
More informationSZF Associates. SZF is an issues-oriented, evidence-based market research and consulting firm serving the pharmaceutical and biotech industry.
SZF Associates Company Mission SZF is an issues-oriented, evidence-based market research and consulting firm serving the pharmaceutical and biotech industry. We work with strategic and tactical decision
More informationReinventing Invention: Advancing Collaboration for Sustainable Bioscience R&D
Reinventing Invention: Advancing Collaboration for Sustainable Bioscience R&D John C. Lechleiter, Ph.D. Chairman, President, and Chief Executive Officer Eli Lilly and Company Washington Biotechnology &
More informationHealthcare and Life Sciences
Healthcare and Life Sciences Introduction Uría Menéndez is an independent law firm that was founded in Madrid in 1946 by Professor Rodrigo Uría González. We currently have seventeen offices in Spain, Portugal,
More informationRICHARD BUTLAND Director
RICHARD BUTLAND Richard Butland is the managing partner of Kite Capital, a growth oriented private investment firm. Prior to establishing Kite Capital, Richard spent 15 years at Goldman Sachs where he
More informationAssociate Director. Biomarker Operations Lead. Business Development & Strategic Alliances. Business Development Executive
Job Title Alliance Lead Analytics Specialist Associate Director Associate Director Diagnostics Partnering Associate Director Business Development Associate Director Application Architecture Associate Manager
More informationGenerics Series: Authorized Generics Analysis Stemming the Generics Tide
Generics Series: Authorized Generics Analysis Stemming the Generics Tide Report summary An overview of the authorized generics landscape, including drivers and resistors for both branded and generics players
More informationTo the shareholders of Nordic Nanovector ASA Oslo, 8 May 2018
To the shareholders of Nordic Nanovector ASA Oslo, 8 May 2018 RECOMMENDATION OF THE NOMINATION COMMITTEE 1. INTRODUCTION The Nomination Committee of Nordic Nanovector ASA comprises of Johan Christenson
More informationTHE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION)
THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION) Feedback from 93 Eastern-European patient groups PUBLISHED JULY 2016 CONTENTS ABOUT THIS REPORT Page 1 WHAT DID
More informationMENTORS REGULATORY AFFAIRS. Christophe AMIEL Head of Medical Device & Digital, Voisin Consulting Life Sciences STRATEGY/BUSINESS
Hosted by : INNOLABS IDEAS CONTEST 21 st -22 nd June, Paris MENTORS REGULATORY AFFAIRS Christophe Amiel is heading the design and operational implementation of international regulatory strategies as Senior
More informationWe Work For Health Champions Awards Class of AstraZeneca: John McCarthy Vice President, Commercial Operations
We Work For Health Champions Awards Class of 2012 Brief Biographical Information (Alphabetical by Member Company) The We Work For Health Champion Awards are given annually to those to individuals who have
More informationEmcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing
More informationFinal Pitch Competition PROGRAM GUIDE. Wednesday, March 2, 2016 at HIMSS16 VENETIAN - PALAZZO - SANDS EXPO CENTER LEVEL 3 - LIDO 3104 LAS VEGAS, NV
Final Pitch Competition PROGRAM GUIDE Wednesday, March 2, 2016 at HIMSS16 VENETIAN - PALAZZO - SANDS EXPO CENTER LEVEL 3 - LIDO 3104 LAS VEGAS, NV #HITVenture #HIMSS16 1 Presented by: WEDNESDAY, MARCH
More informationAqua Pharmaceuticals, LLC
Aqua Pharmaceuticals, LLC Corporate Presentation June 2011 AQUA PHARMACEUTICALS, LLC 1 Company Overview Specialty dermatology pharmaceutical company currently focusing on acquiring, developing and marketing
More informationPlease complete the applicable rows in the following table. Monetary amounts are on an annual basis.
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Year(s): 2016 Name: Shelby D. Reed, PhD Title: Professor Address: PO Box 17969, Durham, NC 27715 Please complete the applicable rows in the following table.
More informationLehigh University Team biographies. October 30, 2017
Lehigh University Team biographies October 30, 2017 Core team members 2 Lane McBride Partner and Managing Director, Washington, DC Lane McBride is a Partner and Managing Director in the Washington, D.C.
More informationLISA TILTON-McCARTHY
LISA TILTON-McCARTHY Lisa Tilton-McCarthy received a B.A. in English from Texas A&M University in College Station and graduated summa cum laude from South Texas College of Law in Houston. She was Editor-in-Chief
More informationForm FI. Management s Discussion and Analysis of Results of Operations and Financial condition for the six months ended April 30, 2007.
Form 51-102FI SERNOVA CORP. Management s Discussion and Analysis of Results of Operations and Financial condition for the six months ended April 30, 2007. The following discussion and analysis should be
More informationV. F. Corporation (Exact Name of Registrant as Specified in Charter)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event
More informationRick Legleiter Appointed Chief Executive Officer, Chairman Succession and Board Renewal Process
Universal Biosensors, Inc. ARBN 121 559 993 1 Corporate Avenue Rowville Victoria 3178 Australia Telephone +61 3 9213 9000 Facsimile +61 3 9213 9099 Email info@universalbiosensors.com www.universalbiosensors.com
More informationPAST AND PRESENT SPEAKER PROFILES
Matteo Carlotti Carlotti (Italy) Matteo Carlotti joined Argos Soditic Italia in February 1997 as an Investment Director involved in sourcing, structuring, negotiating and monitoring equity investments
More informationIntegrated Scientific Advice Workshop: ISPOR Glasgow
Integrated Scientific Advice Workshop: ISPOR Glasgow Early Integrated Scientific Advice in Product Development: Get Real and Adapt to Accelerate Patient Access ICONplc.com Overview At today s patient-centered
More informationCASI Pharmaceuticals, Inc.
CASI Pharmaceuticals, Inc. Your Strategic Drug Development Partner in China NASDAQ: CASI WWW.CASIPHARMACEUTIALS.COM Forward Looking Statements This presentation contains forward-looking statements within
More informationProvincial Appointment to Central Local Health Integration Network Charles Schade Appointed as Vice-Chair of Board of Directors
Announcement 60 Renfrew Drive, Suite 300 Markham, ON L3R 0E1 Tel: 905 948-1872 Toll Free: 1 866 392-5446 Fax: 905 948-8011 www.centrallhin.on.ca Provincial Appointment to Central Local Health Integration
More informationStarpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio
More informationMarket Access 101 Fundamentals of Reimbursement in Canada Wednesday, April 5, 2017
Market Access 101 Fundamentals of Reimbursement in Canada Wednesday, April 5, 2017 John-Paul Dowson, Managing Director, Roubaix Strategies John-Paul brings more than 20 years of experience working in the
More informationSanofi Announces Changes to Executive Committee Aligned to its Strategic Roadmap 2020
PRESS RELEASE Sanofi Announces Changes to Executive Committee Aligned to its Strategic Roadmap 2020 Paris, France May 23, 2016 - Sanofi Chief Executive Officer Olivier Brandicourt, MD, announced today
More informationManagement to Host Conference Call at 8:30 a.m. ET today
Aclaris Therapeutics Reports Second Quarter 2016 Financial Results August 11, 2016 7:01 AM ET Management to Host Conference Call at 8:30 a.m. ET today MALVERN, Pa., Aug. 11, 2016 (GLOBE NEWSWIRE) -- (NASDAQ:ACRS),
More informationPANEL DISCUSSION & ROUNDTABLES
LIFE SCIENCES & HEALTH CARE EVENT Road to commercialization - Challenges, Opportunities & Successes that lie ahead in the Life Sciences and Healthcare Sectors Life Sciences and Healthcare is one of the
More informationCorporate Presentation July 2017
Corporate Presentation July 2017 Forward Looking Statements Certain statements contained in this presentation constitute forward-looking information and forwardlooking statements (collectively, "forward-looking
More informationInnovation and the Changing Practice of Medicine
Innovation and the Changing Practice of Medicine Japan Medical Innovation Symposium David Epstein, Division Head Novartis Pharmaceuticals Tokyo, August 18, 2015 Agenda The Case for Innovation How Novartis
More informationCorporate Compliance & Transparency
4 th Annual Conference Corporate Compliance & Transparency in the Pharmaceutical Industry 24 25 February 2016 Zürich, Switzerland Conference In Numbers 84 Attendees 2 Days 29 Speakers 19 Participating
More informationVenture Capital Search Highlights
Venture Capital Venture funding continued at the strongest pace witnessed over the past decade in 2016, and recruiting the future leaders of the industry s emerging growth companies has never been more
More informationLupin Limited Annual Results FY12. Investor Presentation May being
Lupin Limited Annual Results FY12 Investor Presentation May 2012 Vision: To be an innovation led transnational company Journey over the last decade 5th largest generics player in US Gross Revenues INR
More informationBREAKTHROUGH CONVENTION SUMMARY JUNE SAN DIEGO CONVENTION.BIO.ORG #BIO2017
BREAKTHROUGH CONVENTION SUMMARY JUNE 19-22 SAN DIEGO CONVENTION.BIO.ORG #BIO BIO BY THE NUMBERS FEATURING SEVERAL THEMATIC EXHIBITS 16,123 ATTENDEES 74 48 COUNTRIES STATES 18,000 MORE THAN EXHIBITORS 41,400
More informationAnnual Benefit-Risk Workshop
Annual Benefit-Risk Workshop Implementing an Internationally Acceptable Framework for the Benefit- Risk Assessment of Medicines: How close are we to this objective? 20-21 June 2013 PROGRAMME Venue: The
More informationBoard of Governors (BOG)
Board of Governors (BOG) Members Eligible for Re-appointment 2017-18 Nancy Brown Andison and Alumni Nancy Brown Andison is a retired Partner of PricewaterhouseCoopers and an Executive of IBM Canada. A
More informationANNUAL GENERAL MEETING OF SHAREHOLDERS AFFIMED N.V.
ANNUAL GENERAL MEETING OF SHAREHOLDERS AFFIMED N.V. to be held on Tuesday, June 19, 2018 at 15:00 hrs. (CET) at Amsterdam Marriott Hotel, Stadhouderskade 12, 1054 ES Amsterdam, the Netherlands Agenda 1
More informationINDIAN SOCIETY FOR CLINICAL RESEARCH
INDIAN SOCIETY FOR CLINICAL RESEARCH 12 th Annual Conference Clinical Research Advancing the Frontiers of Health February 15-16, 2019, New Delhi Pre-Conference Workshops February 14, 2019 Track III Biostatistics
More informationData-Driven Evaluation: The Key to Developing Successful Pharma Partnerships
R&D Solutions for PHARMA & LIFE SCIENCES DRUG DISCOVERY & DEVELOPMENT Data-Driven Evaluation: The Key to Developing Successful Pharma Partnerships Summary For pharmaceutical companies to succeed, it is
More information2 Decades On: Perspectives from the Asian Financial Crisis: New Risks and Opportunities Take Shape.
AGENDA 8:30AM 9:00AM 9:05AM REGISTRATION & BREAKFAST OPENING REMARKS KEYNOTE ADDRESS Asia Pacific 20 Years After the Crisis Causes and lessons learned (or not) Is Asia still the fastest growing region
More information2012 North American Laboratory Researchers Choice: Future Market Leader of Digital PCR Technology Award
2011 South African Data Centre Green Excellence Award in Technology Innovation Cybernest 2012 2012 North American Laboratory Researchers Choice: Future Market Leader of Digital PCR Technology Award 2011
More informationBIC 2022 Invent the Future
BIC GROUP PRESS RELEASE CLICHY 13 FEBRUARY 2019 BIC 2022 Invent the Future FOUR STRATEGIC PILLARS TO DRIVE LONG TERM PROFITABLE SALES GROWTH A FOCUSED AND AGILE ORGANIZATION UNCHANGED CAPITAL ALLOCATION
More informationCeQur establishes Wales subsidiary
FOR IMMEDIATE RELEASE CeQur establishes Wales subsidiary -- Arthurian Life Sciences investment helps bring to market world s first three-day simple insulin infusion device for type 2 diabetes -- LUCERNE,
More informationWhere the brightest scientific minds thrive. IMED Early Talent and Post Doc programmes
Where the brightest scientific minds thrive. IMED Early Talent and Post Doc programmes Scientific innovation is at the heart of everything we do. Scientific innovation is at the heart of our business and
More informationAmy Bryson, BA (Hon), LL.B, ICD.D
CAA CLUB GROUP ELECTION OF DIRECTORS BIOGRAPHIES OF THE FIVE DIRECTORS UP FOR RE-ELECTION ARE PROVIDED HERE: Amy Bryson, BA (Hon), LL.B, ICD.D A member of the CAA South Central Ontario Board of Directors
More informationSPEAKER BIOGRAPHIES. Sarah Abbas
SPEAKER BIOGRAPHIES Sarah Abbas Sarah Abbas currently supports global medical education through collaboration with Pfizer Country Offices. She developed and managed the WW Investigator Initiated Research
More informationBorn Ph.D. from Karolinska Institutet in Stockholm. Board member since 2016.
Board of Directors Håkan Björklund Chairman Born 1956. Ph.D. from Karolinska Institutet in Stockholm. Board member since 2016. Other appointments: Currently serves as Industry Executive at Avista Capital
More informationPresentation. March 2007
Presentation March 2007 1 Corporate Overview 2 Corporate Overview Leading provider of research-driven packaging solutions solely-focused on pharmaceutical industry Founded in 1994 and based in Pune, India
More informationPre WRA - Asia. Axens Refining & Petrochemicals Seminar Singapore - 23 October Program & Speakers Biographies
Program & Speakers Biographies 08:30 Welcome Address & Opening Remarks 08:40 Asia Refining and Petrochemical Challenges 09:00 Clean Fuels Challenges - Introduction - Clean Gasoline Production - Reforming
More informationState of Licensing 2011 Update
State of Licensing 2011 Update Moderators/Speakers Hemmie Chang, Chair, Licensing & Strategic Alliance Practice Group, Foley Hoag LLP Ranya Dajani, Executive Director, Strategic Transactions Group, Bristol-
More informationJOHN JACK R. TUPMAN, JR CURRICULUM VITAE
JOHN JACK R. TUPMAN, JR CURRICULUM VITAE September 2018 John R. Tupman, Jr. is a consultant focused on business development and licensing in the life sciences industry. He is currently working as a consultant
More informationVanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sector Publishing Intelligence Limited
More informationLIGAND PHARMACEUTICALS INCORPORATED (Exact Name of Registrant as Specified in Its Charter)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event
More informationTreasury and Trade Solutions Citi Commercial Cards. A History of Achievement. A Future of Innovation. May 19-21, 2014
Treasury and Trade Solutions Citi Commercial Cards A History of Achievement. A Future of Innovation. May 19-21, 2014 Communicating and Marketing Your Program Internally Pauline Smith Carla Vitaliano, The
More informationNUS Institute of Systems Science appoints Janet Ang as new Chairperson
PRESS RELEASE 31 MARCH 2016 FOR IMMEDIATE RELEASE NUS Institute of Systems Science appoints Janet Ang as new Chairperson Tech veteran succeeds Institute s longest serving Chairman Professor Christopher
More information(3) Educational Activities or Lectures for this Company Generates Revenue for Duke $5K $25K >$25K
DCRI Commercial relationships Tracking Form Year: 2018 Name: Adrian Hernandez, M.D. Title: Vice Dean, Clinical, School of Medicine Address: 200 Trent Dr., Durham NC 27710 Please complete the applicable
More informationResearch Brief. Clinicians and life sciences companies working together: What types of relationships do clinicians find most appealing?
Research Brief Clinicians and life sciences companies working together: What types of relationships do Truven Health Analytics was acquired by IBM in 2016 to help form a new business, Watson Health. Watson
More informationComprehensive Research Services
Comprehensive Research Services Scripps Health: At the Forefront of Clinical Research Scripps Health is a recognized leader in clinical research and has long been at the forefront of numerous medical breakthroughs.
More informationMedAdNews. themagazineofpharmaceuticalbusinessandmarketing medadnews.com october2007. What leaders need
MedAdNews themagazineofpharmaceuticalbusinessandmarketing medadnews.com october2007 What leaders need Leaders from across the pharmaceutical and biotechnology industry discuss the experiences and characteristics
More informationIvanhoé Cambridge appoints Claude Sirois President, Ivanhoé Cambridge Retail
NEWS RELEASE FOR IMMEDIATE RELEASE Ivanhoé Cambridge appoints Claude Sirois President, Ivanhoé Cambridge Retail An Executive Committee made up of seasoned professionals Montreal, Quebec, May 20, 2016 Ivanhoé
More informationDCRI COMMERCIAL RELATIONSHIPS TRACKING FORM
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report information for the calendar year 2014 and anticipated
More informationPrevious Attendees List:
Previous Attendees List: Company 3M Abbott Abbott Point of Care Abbott Vascular ACIST Medical ACIST Medical Systems Adamas Pharmaceuticals Aileron Holdings Allergan Allergan Allergan Ansell Healthcare
More informationForward Looking Statements
Corporate Presentation January, 2017 Forward Looking Statements Certain statements contained in this presentation constitute forward-looking information and forwardlooking statements (collectively, "forward-looking
More informationLocal Production of Pharmaceuticals and Related Technology Transfer UNCTAD/CD-TFT 1. Background
Local Production of Pharmaceuticals and Related Technology Transfer Dr. Padmashree Gehl Sampath Division for Technology and Logistics UNCTAD UNCTAD/CD-TFT 1 1 Background Case studies part of the EU funded
More informationTerri Bradford Eason manages the foundation s Gift Planning Program as a member of the Advancement team. Her primary focus is cultivating
Terri Bradford Eason manages the foundation s Gift Planning Program as a member of the Advancement team. Her primary focus is cultivating relationships that help individuals establish current and deferred
More informationAstraZeneca 2013 AGM
AstraZeneca 2013 AGM Chief Executive s Remarks 25 April 2013 Introduction Thank you, Leif. Ladies and gentlemen, good afternoon. I would like to add my own welcome to you this afternoon and thank you for
More informationINDIAN SOCIETY FOR CLINICAL RESEARCH
INDIAN SOCIETY FOR CLINICAL RESEARCH 12 th Annual Conference Clinical Research Advancing the Frontiers of Health February 15-16, 2019, New Delhi Pre-Conference Workshops February 14, 2019 Workshop - Career
More informationgellerbiopharm A healthcare investment banking division of Financial West Group, member FINRA/SIPC. Office (212) Web gellerbp.
gellerbiopharm A healthcare investment banking division of Financial West Group, member FINRA/SIPC. Office (212) 315-0600 Web gellerbp.com Summary Personal Diverse, world-class team of top biotech bankers,
More informationTRENDS IN IP DISPUTES
ASSOCIATION OF CORPORATE COUNSEL LITIGATION COMMITTEE APRIL 25, 2017 TRENDS IN IP DISPUTES DAVID YURKERWICH MANAGING DIRECTOR IP PRACTICE LEADER 1 AGENDA Patent infringement and IPR filing trends Operating
More informationTRANSLATIONAL SCIENCE
TRANSLATIONAL SCIENCE A Discussion of Best Practices and Unique Models Wednesday January 31, 2018 at The NYSCF Research Institute HRA TRI-STATE REGIONAL MEETING 31 Wednesday January, 2018 AGENDA 8:30 AM
More informationKoen Dejonckheere. Professional experience. Board Memberships. Education
Koen Dejonckheere Professional experience KBC SECURITIES GROUP 2002-2008 Managing Director, responsible for Corporate Finance Previously, Koen Dejonckheere was active in Corporate Finance and Private Equity
More informationOwnership/ Partnership/ Principal. None None None Lantheus Medical Imaging (DSMB) NIH (DSMB)* None None None None None None
AUTHOR RELATIONSHIPS WITH INDUSTRY AND OTHER ENTITIES (Comprehensive) ACCF/AHA 2013 GUIDELINE FOR THE MANAGEMENT OF ST-ELEVATION MYOCARDIAL INFARCTION (October, 2012) Committee Member Patrick T. O Gara,
More informationSandra Sanchez y Oldenhage General Manager Probiomed
Sandra Sanchez y Oldenhage General Manager Probiomed Sandra Sanchez y Oldenhage has 26 years of executive level experience in top ranked pharmaceutical companies such as Pfizer, Merck Sharp & Dohme, Searle
More informationLife Sciences Outlook. New York City 2016
Life Sciences Outlook City 2016 City is emerging as a leading destination for biotech startups and the larger life sciences industry. Investors have committed millions of dollars throughout the city and
More informationINVESTOR PRESENTATION!
INVESTOR PRESENTATION ENHANCING HEALTH THROUGH CANNABIS SCIENCE WWW.EMERALDHEALTH.CA TSX.V:EMH TSX.V:EMH Disclaimer THE STATEMENTS MADE IN THIS PRESENTATION MAY INCLUDE FORWARD-LOOKING STATEMENTS REGARDING
More informationLUPIN LIMITED Q3FY17 Investor Presentation February 09, 2017
LUPIN LIMITED Investor Presentation February 09, 2017 Safe Harbor Statement Materials and information provided during this presentation may contain forward-looking statements. These statements are based
More informationManagement Team. Bruce C. Cozadd Chairman and Chief Executive Officer
Bruce C. Cozadd Chairman and Chief Executive Officer Bruce Cozadd joined Jazz Pharmaceuticals at its inception and was appointed Jazz Pharmaceuticals Chief Executive Officer in April 2009. From 2003 until
More informationGlobal Source Ventures, LLC Introduction. Antonius Schuh Managing Partner Stephen Zaniboni Managing Partner
Global Source Ventures, LLC Introduction Antonius Schuh Managing Partner Stephen Zaniboni Managing Partner Introduction to Global Source Ventures GSV provides seed capital to emerging companies with emphasis
More informationFeature. Accelerate Business Development Contributing to Further Enhance Ophthalmic Treatment in Asia. 2020, our goal is to become #1 in
Feature Accelerate Business Development Contributing to Further Enhance Ophthalmic Treatment in Asia Based on our long-term strategic vision toward 2020, our goal is to become #1 in Asia in terms of our
More information